Sign in

CIK 0001572616

  • Non-accelerated filer
  • Smaller reporting company
  • Emerging growth company

FRACTYL HEALTH, INC.

Sign in to watch
Ticker
GUTS
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
273553477
Phone
+1 781-902-8800
Business address
3 VAN DE GRAAFF DRIVE, SUITE 200, BURLINGTON, MA, 01803
Former names
Fractyl Laboratories Inc.
Open-market buys, last 90 days
$39,903
in 1 filing
Open-market sales, last 90 days
$0
in 0 filings

Net +$39,903. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. BRADLEY WILLIAM +$40K Director 1 filing
Date Insider Transaction Shares Price Value Owned after
2025-12-15 Caplan Jay David President, Chief Product Off. Grant or award · Stock Option (right to buy) +845,226 845,226
2025-02-27 Caplan Jay David President, Chief Product Off. Grant or award · Stock Option (right to buy) +179,700 179,700
2025-02-27 Caplan Jay David President, Chief Product Off. Grant or award · Stock Option (right to buy) +104,400 104,400
2025-01-31 Caplan Jay David President, Chief Product Off. Exercise or conversion 10b5-1 +22,346 $1.70 $38K 175,890
2025-01-31 Caplan Jay David President, Chief Product Off. Sale 10b5-1 −22,346 $1.81 $40K 153,544
2025-01-31 Caplan Jay David President, Chief Product Off. Exercise or conversion · Stock Option 10b5-1 −22,346 17,924
2025-01-30 Caplan Jay David President, Chief Product Off. Exercise or conversion 10b5-1 +21,472 $1.70 $37K 175,016
2025-01-30 Caplan Jay David President, Chief Product Off. Sale 10b5-1 −21,472 $1.95 $42K 153,544
2025-01-30 Caplan Jay David President, Chief Product Off. Exercise or conversion · Stock Option 10b5-1 −21,472 40,270
2024-11-11 Caplan Jay David President, Chief Product Off. Sale −64,197 $2.47 $159K 153,544
2024-11-10 Caplan Jay David President, Chief Product Off. Exercise or conversion +187,257 217,741
2024-11-10 Caplan Jay David President, Chief Product Off. Exercise or conversion · Restricted Stock Unit −187,257 0
2024-09-12 Caplan Jay David President, Chief Product Off. Exercise or conversion +95,484 $1.70 $162K 95,484
2024-09-12 Caplan Jay David President, Chief Product Off. Sale −65,000 $2.90 $188K 30,484
2024-09-12 Caplan Jay David President, Chief Product Off. Exercise or conversion · Stock Option −95,484 0
2024-02-06 Caplan Jay David President, Chief Product Off. Conversion +23,299 358,806
2024-02-06 Caplan Jay David President, Chief Product Off. Conversion +118,810 118,810
2024-02-06 Caplan Jay David President, Chief Product Off. Conversion · Series A Preferred Stock −50,000 0
2024-02-06 Caplan Jay David President, Chief Product Off. Conversion · Series B Preferred Stock −177,726 0
2024-02-06 Caplan Jay David President, Chief Product Off. Conversion · Series C-1 Preferred Stock −44,730 0

Page 1 of 2 · 21 trades